That's important, because the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (legacy report prediction). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a development nearly nobody saw. However it's going to have extensive implications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be a lot of financial investment opportunities in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (exponential growth). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe significantly prior to going greater - jeff brown biotech picks. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. However that's not the big question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. last year. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so numerous fantastic private companies on the verge of striking the general public markets And I have actually been working on a new way for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to schedule your area totally free.
Emma Walsh here, handling editor of the Journal. Routine Diary readers understand that tech isn't our typical beat (biotech stock). And when it comes to tech investing, we leave it to the experts. The good news is, we have a number of such experts in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (what is the legacy report predicting). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and predict what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and much more. These trends are experiencing rapid growth and producing unbelievable chances for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff bezos. But regardless of what numerous readers may think, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled devices were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown genetic sequencer stock). Losing 2 months of production and sales actually affects the number of 5G devices are sold in the calendar year. When you consider all of that, selling 250 million systems is amazing. More significantly, the hold-ups brought on by the pandemic produced a lots of pent-up need. And that need is now going to be pushed into 2021. In fact, I forecast that more than 500 million 5G devices will be delivered in 2021 - tech stock. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually explained its three various stages.
In Phase 2, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Phase Three, 5G services begin to be used (brownstone research). That's when we begin to see applications operating on 5G networks. Consider things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage 3 by this summer. This begins something of a virtuous cycle: Many people do not truly appreciate the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next essential innovation I foresee in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For several years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And during that time, there were really just 3 companies running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is successfully a greenfield chance.
There's room for numerous companies to exist in this area. longtime readers. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software can precisely predict the folding of a protein based solely on its amino acid series with 92. 4% precision. That's essential because the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced utilizing this innovation. This was one of those advancements that almost no one saw. However it's going to have extensive implications for curing disease. And, obviously, there will be plenty of investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe significantly before going greater. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin - korean actress. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. But at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. biotech stock. Mass, Mutual is a 150-year-old organization. So believe about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date as of February 2021, but we could not individually verify this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like ability to choose winning innovation stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent perspective on the market. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully anticipated some of the biggest economic occasions of the past twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it right every time, but Jeff Brown's precise forecasts have actually made him legions of dedicated fans. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a prominent monetary research publisher. Brownstone Research study uses numerous research study services with a variety of specializations - artificial intelligence.
The company is also connected with Bonner & Partners, another well-respected research publisher - jeff brown. On its website, Brownstone states its objective is to offer retail investors with professional-grade research: "For too long, the very best financial investment research has not been available to private financiers. It has actually been typically booked for financial investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown investor prediction. The mission of Brownstone Research is to make that sort of proprietary research readily available to any financiers looking to acquire an edge in the markets. The goal is basic to deliver unique and rewarding financial investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise acts as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you know even a little bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. melania trump. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown believes S.A.V. jeff brown top stock pick 2021. might be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying two cutting-edge innovations: synthetic intelligence and electrical cars. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the vehicle industry's Holy Grail. As you understand, electric lorries and self-driving vehicle stocks have been huge this year, however the Wall Street machine has actually approved buzz without much concrete outcome. In spite of a drastic increase in competitors over the past few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that connects it all together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transport. Basically, this innovation would enable you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the cars and truck and press a button on an app that informs the vehicle to "join the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the revenues. It sounds ridiculous, however it might be closed than you think.